Christopher Gunderson spent the first 16 years of his life unable to eat and in desperate need of medical intervention for ...

Christopher Gunderson spent the first 16 years of his life unable to eat and in desperate need of medical intervention for survival.

After having an emergency c-section, Tru now lives with condition which she believes was a result of her difficult pregnancy. After her experience, the Essex mother now uses one prescribed treatment ...

In patients with T1D, cannabinoid hyperemesis syndrome and diabetic gastroparesis have similar symptoms but different ...

Functional dyspepsia (FD) and gastroparesis (GP) are gastrointestinal disorders often managed as separate conditions.

Gastroparesis is a chronic gastrointestinal condition that happens when the stomach can’t empty well, causing delayed ...

Functional dyspepsia (FD) and gastroparesis (GP) are gastrointestinal disorders often managed as separate conditions. FD is classified as a disorder of gut-brain interaction (DGBI), characterized by ...

A groundbreaking review in eGastroenterology examines the overlap between functional dyspepsia (FD) and gastroparesis (GP), two gastrointestinal disorders traditionally viewed as distinct. New ...

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

Good afternoon, and welcome to the Evoke Pharma fourth quarter and full-year 2024 earnings conference call. (Operator Instructions) Please be advised that today's call is being recorded. I would now ...

Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...

"2024 was a transformative year for Evoke Pharma, as we successfully executed on key commercial and strategic initiatives that drove strong revenue growth, expanded patient access to GIMOTI, and ...